Gene: SLC1A4
Official Full Name: solute carrier family 1 member 4provided by HGNC
Gene Summary: The protein encoded by this gene is a sodium-dependent neutral amino acid transporter for alanine, serine, cysteine, and threonine. Defects in this gene have been associated with developmental delay, microcephaly, and intellectual disability. [provided by RefSeq, Jan 2017]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO05732 | SLC1A4 Knockout cell line (HeLa) | Human | SLC1A4 | 1:3~1:6 | Negative | Online Inquiry |
KO05733 | SLC1A4 Knockout cell line (HCT 116) | Human | SLC1A4 | 1:2~1:4 | Negative | Online Inquiry |
KO05734 | SLC1A4 Knockout cell line (HEK293) | Human | SLC1A4 | 1:3~1:6 | Negative | Online Inquiry |
KO05735 | SLC1A4 Knockout cell line (A549) | Human | SLC1A4 | 1:3~1:4 | Negative | Online Inquiry |
SLC1A4 Gene Knockout Cell Lines are specifically engineered cellular models characterized by the targeted disruption of the SLC1A4 gene, which encodes a key transporter involved in neurotransmitter uptake, particularly glutamate. These knockout models facilitate the in-depth study of the physiological and pathological roles of this glutamate transporter in various biological contexts. By establishing precise genomic deletions, researchers can investigate the downstream effects of altered glutamate homeostasis on neuronal viability, synaptic transmission, and neurodegenerative processes.
The primary function of SLC1A4 in cellular metabolism and neurotransmission underscores its significance in both normal physiology and disease states. The knockout cell lines allow for the exploration of the ramifications of SLC1A4 loss, including implications in neurological disorders such as schizophrenia, autism spectrum disorders, and related neurodevelopmental conditions. The unique mechanisms underpinning the alterations in cellular activity provide invaluable insights into therapeutic targets and biomarkers.
Compared to traditional cell lines that lack such specific alterations, SLC1A4 Gene Knockout Cell Lines offer distinct advantages, including their capacity for generating reproducible experimental data reflective of genetic disruptions found in human pathology. This specificity enables researchers to dissect the functions of this transporter more effectively and assess potential pharmacological interventions.
For researchers and clinicians alike, these cell lines represent essential tools for translational research, bridging the gap between basic science and clinical applications. By utilizing SLC1A4 knockout models, users can pioneer advancements in understanding disease mechanisms and developing novel therapies.
At our company, we pride ourselves on delivering high-quality, reliable biological products backed by stringent quality controls and a commitment to innovation. Our expertise in genetic engineering and cell line development ensures that you have access to cutting-edge tools that enhance your research capabilities and contribute to breakthroughs in health science.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.